v3.25.4
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:        
Net loss $ (2,249,887) $ (4,432,829) $ (5,137,332) $ (3,712,047)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation 1,132,500 2,258,080 2,966,115 2,043,909
Amortization of beneficial conversion feature     261,062
Amortization of debt discount 19,490 19,490 45,266
Change in assets and liabilities:        
Prepaid expenses 73,985 (113,092) (82,882) (21,624)
Other receivable (22,248)    
Accounts payable and accrued expenses 191,225 (52,400) (176,573) 78,757
Accrued expenses - related party 140,000 22,676 (366,295) 288,689
Accrued interest 274,874 226,276 273,969 147,560
Net cash used in operating activities (459,551) (2,071,799) (2,503,508) (868,428)
Cash flows from financing activities:        
Proceeds from convertible notes payable     202,200
Proceeds from note payable 102,000 25,000 100,000
Repayment of debenture     (5,000)
Proceeds from exercise of warrants 258,940 384,000
Proceeds from sale of preferred stock, net 2,035,384 2,095,040 265,000
Net cash provided by financing activities 360,940 2,060,384 2,574,040 467,200
Net change in cash (98,611) (11,415) 70,532 (401,228)
Cash at beginning of period 100,678 30,146 30,146 431,374
Cash at end of period 2,067 18,731 100,678 30,146
Cash paid for interest 11,785 110,712
Cash paid for taxes
Non-cash investing and financing activities:        
Conversion of convertible notes payable 1,048,793 1,048,793 269,085
Cashless exercise of warrants and options $ 20,563 20,563
Conversion of accounts payable into common stock     $ 30,000